<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Medicine (Baltimore)</journal-id><journal-id journal-id-type="iso-abbrev">Medicine (Baltimore)</journal-id><journal-id journal-id-type="publisher-id">MD</journal-id><journal-title-group><journal-title>Medicine</journal-title></journal-title-group><issn pub-type="ppub">0025-7974</issn><issn pub-type="epub">1536-5964</issn><publisher><publisher-name>Lippincott Williams &#x00026; Wilkins</publisher-name><publisher-loc>Hagerstown, MD</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">40388753</article-id><article-id pub-id-type="pmc">PMC12091651</article-id>
<article-id pub-id-type="publisher-id">MD-D-24-15953</article-id><article-id pub-id-type="art-access-id">00034</article-id><article-id pub-id-type="doi">10.1097/MD.0000000000042553</article-id><article-version vocab="JAV" vocab-identifier="http://www.niso.org/publications/rp/RP-8-2008.pdf" article-version-type="Version of Record">3</article-version><article-categories><subj-group subj-group-type="heading"><subject>4000</subject></subj-group><subj-group><subject>Research Article</subject><subject>Clinical Case Report</subject></subj-group></article-categories><title-group><article-title>Systemic sclerosis complicating endometrial adenocarcinoma: A case report</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-5973-1970</contrib-id><name><surname>Yan</surname><given-names>Hui-Chang</given-names></name><degrees>MM</degrees><xref rid="aff1" ref-type="aff">a</xref><xref rid="c1" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><name><surname>Huang</surname><given-names>Cui</given-names></name><degrees>MB</degrees><email>13683713962@139.com</email><xref rid="aff1" ref-type="aff">a</xref></contrib><aff id="aff1"><label>a</label>Department of Dermatology, Henan General Hospital, Zhengzhou, Henan Province, China.</aff></contrib-group><author-notes><corresp id="c1"><label>*</label>Correspondence: Hui-Chang Yan, No. 71 Nongye Road, Zhengzhou 470000, Henan Province, China (e-mail: <email xlink:href="yanhuichang120@126.com">yanhuichang120@126.com</email>).</corresp></author-notes><pub-date pub-type="collection"><day>16</day><month>5</month><year>2025</year></pub-date><pub-date pub-type="epub"><day>16</day><month>5</month><year>2025</year></pub-date><volume>104</volume><issue>20</issue><elocation-id>e42553</elocation-id><history><date date-type="received"><day>24</day><month>12</month><year>2024</year></date><date date-type="received"><day>18</day><month>4</month><year>2025</year></date><date date-type="accepted"><day>22</day><month>4</month><year>2025</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2025 the Author(s). Published by Wolters Kluwer Health, Inc.</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article distributed under the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License 4.0 (CCBY)</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:href="medi-104-e42553.pdf"/><abstract><sec><title>Rationale:</title><p>Systemic sclerosis (SSc) is a rare systemic autoimmune disease, and it is even more uncommon to encounter it alongside a neoplasm.</p></sec><sec><title>Patient concerns:</title><p>A 55-year-old female patient presented to our clinic with a 7-year history of cyanosis affecting multiple fingers bilaterally, accompanied by Raynaud&#x02019;s phenomenon, mild pain, numbness, and morning stiffness. One and a half years ago, she was diagnosed with endometrial adenocarcinoma (Federation International of Gynecology and Obstetrics stage IIIa) for frequent abdominal pain and abnormal vaginal bleeding.</p></sec><sec><title>Diagnoses:</title><p>Following a comprehensive physical examination and laboratory tests, she was diagnosed with SSc according to the 2013 American College of Rheumatology/European League Against Rheumatism classification criteria.</p></sec><sec><title>Interventions:</title><p>Although we discussed potential treatment options and prognosis with her, she ultimately declined therapy.</p></sec><sec><title>Outcomes:</title><p>She was lost to follow-up.</p></sec><sec><title>Lessons:</title><p>A shared pathophysiological process may underlie the development of both SSc and malignancy, possibly driven by persistent chronic inflammation and immune dysregulation.</p></sec></abstract><kwd-group><kwd>endometrial adenocarcinoma</kwd><kwd>malignancy</kwd><kwd>pathogenesis</kwd><kwd>scleroderma</kwd><kwd>systemic sclerosis</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>OPEN-ACCESS</meta-name><meta-value>TRUE</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro"><title>1. Introduction</title><p>Systemic sclerosis (SSc) is an uncommon chronic multisystemic autoimmune disease characterized by dysregulated autoimmunity, microvasculopathy, and fibrosis of skin and visceral organs, with hitherto elusive etiology.</p><p>Though rarer, there are some reports of SSc with concomitant neoplasm, even accounting for some mortality. Solid organ cancers involving the lung (most common), breast, colon-rectum, liver, bladder, kidney, pancreas, esophagus, tongue, skin, cervix, etc, and hematological cancers (lymphoma, leukemia, multiple myeloma, and myeloproliferative disorders) have been reported to be concomitant.<sup>[<xref rid="R1" ref-type="bibr">1</xref>,<xref rid="R2" ref-type="bibr">2</xref>]</sup> Although some instances of SSc occurring alongside various malignancies have been documented, the underlying mechanisms linking the 2 remain poorly understood. This underscores a significant research gap in exploring the shared pathophysiological pathways, genetic and environmental influences, and effective clinical management strategies for patients presenting with both conditions. Here, we present a rare case of SSc accompanied by endometrial adenocarcinoma.</p></sec><sec sec-type="cases"><title>2. Case report</title><p>A 55-year-old female visited our clinic with a 7-year history of cyanosis of multiple fingers in both hands on March 16, 2023. Initially, cyanosis emerged after grasping the snowball, with various accompanying symptoms, such as the Raynaud phenomenon, mild pain, numbness, and morning stiffness, which may resolve partially after exercise. Occasional left knee ache, oral dryness, eye dryness, and muscle pain were also mentioned, without oral ulcer, alopecia, photosensitivity, or fatigue. Lesions progressively involved more fingers and crept to the proximal part in the last 2 years. One and a half years ago, frequent abdominal pain and abnormal vagina hemorrhages led her to visit a gynecologist, and she was diagnosed with endometrial adenocarcinoma (Federation International of Gynecology and Obstetrics staging IIIa) after a comprehensive screening. At the same time, some interstitial changes in the lower lobes of both lungs (Fig. <xref rid="F1" ref-type="fig">1</xref>) were also found simultaneously but overlooked. She underwent total abdominal hysterectomy, bilateral salpingo-oophorectomy, omentectomy, and pelvic lymph node dissection first, followed by 4 courses of chemotherapy with the scheme of paclitaxel and paraplatin and 2 classes of radiotherapy. During follow-up, no recurrence was found. Besides a 10-year history of type 2 diabetes mellitus, treated with dimethylbiguanide but with inadequate glycemic control, there were no other comorbidities.</p><fig position="float" id="F1"><label>Figure 1.</label><caption><p>Computed tomography found some interstitial changes in the lower lobes of both lungs.</p></caption><graphic xlink:href="medi-104-e42553-g001" position="float"/></fig><p>Physical examination revealed cyanosis and mild swell involving all fingers with lowered skin temperature and moderate tenderness (Fig. <xref rid="F2" ref-type="fig">2</xref>), some millet size atrophic scar in the fingertip of both index finger and right middle finger (Fig. <xref rid="F3" ref-type="fig">3</xref>), diffuse hazel pigmentation in the face, and mild tenderness in the left knee.</p><fig position="float" id="F2"><label>Figure 2.</label><caption><p>Cyanosis and mild swell in all fingers.</p></caption><graphic xlink:href="medi-104-e42553-g002" position="float"/></fig><fig position="float" id="F3"><label>Figure 3.</label><caption><p>Some millet-sized atrophic scars are on the tip of both index finger and right middle finger.</p></caption><graphic xlink:href="medi-104-e42553-g003" position="float"/></fig><p>According to her exceptional condition, we performed some primary screening examinations (Table <xref rid="T1" ref-type="table">1</xref>). According to the 2013 American College of Rheumatology\European League Against Rheumatism criteria for the classification of SSc, the total score of our case was 13, which fulfilled the classification criteria (&#x02265;9), so a final diagnosis of SSc was made. However, she refused to receive therapy while she was informed of the following possible treatment and prognosis.</p><table-wrap position="float" id="T1"><label>Table 1</label><caption><p>Summary of results of screening examinations.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Examinations (reference value)</th><th align="center" rowspan="1" colspan="1">Results</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Total white blood cell count ([4&#x02013;10]&#x02005;&#x000d7;&#x02005;10<sup>9</sup>/L)</td><td align="center" rowspan="1" colspan="1">3.34&#x02005;&#x000d7;&#x02005;10<sup>9</sup>/L</td></tr><tr><td align="left" rowspan="1" colspan="1">Urine glucose (negative)</td><td align="center" rowspan="1" colspan="1">1+</td></tr><tr><td align="left" rowspan="1" colspan="1">Fast blood glucose (3.89&#x02013;6.11 mmol/L)</td><td align="center" rowspan="1" colspan="1">8.38 mmol/L</td></tr><tr><td align="left" rowspan="1" colspan="1">Anti-Scl-70 antibodies (negative)</td><td align="center" rowspan="1" colspan="1">(+)</td></tr><tr><td align="left" rowspan="1" colspan="1">Antinuclear antibody (negative)</td><td align="center" rowspan="1" colspan="1">(+), homogeneous pattern at titers 1:320</td></tr><tr><td align="left" rowspan="1" colspan="1">Rheumatoid factor (negative)</td><td align="center" rowspan="1" colspan="1">Negative</td></tr><tr><td align="left" rowspan="1" colspan="1">Antiphospholipid antibodies (negative)</td><td align="center" rowspan="1" colspan="1">Negative</td></tr><tr><td align="left" rowspan="1" colspan="1">Anti-neutrophil cytoplasm antibodies (negative)</td><td align="center" rowspan="1" colspan="1">Negative</td></tr><tr><td align="left" rowspan="1" colspan="1">Glutamic-pyruvic transaminase, glutamic oxaloacetic transaminase (0&#x02013;40 U/L)</td><td align="center" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">Complement 3 (0.9&#x02013;1.5 g/L)</td><td align="center" rowspan="1" colspan="1">0.11</td></tr><tr><td align="left" rowspan="1" colspan="1">Complement 4 (0.2&#x02013;0.4 g/L)</td><td align="center" rowspan="1" colspan="1">0.32</td></tr><tr><td align="left" rowspan="1" colspan="1">Erythrocyte sedimentation rate (0&#x02013;20 mm/h)</td><td align="center" rowspan="1" colspan="1">15</td></tr><tr><td align="left" rowspan="1" colspan="1">C-reactive protein (0&#x02013;5 mg/L)</td><td align="center" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">Electrocardiogram</td><td align="center" rowspan="1" colspan="1">Normal</td></tr><tr><td align="left" rowspan="1" colspan="1">Computed tomography</td><td align="center" rowspan="1" colspan="1">Interstitial changes in both lower lung lobes</td></tr></tbody></table></table-wrap></sec><sec sec-type="discussion"><title>3. Discussion</title><p>SSc is a multisystem autoimmune disorder marked by microvascular dysfunction and immune abnormalities, leading to fibrosis of the skin and internal organs. Thick, hardened skin is the distinctive disease manifestation; hence, it has also been termed a &#x0201c;hidebound disease.&#x0201d; The skin over the extremities, face, and trunk may exhibit hyperpigmentation, with distinct depigmented regions. A &#x0201c;salt and pepper&#x0201d; appearance, characterized by vitiligo-like depigmentation and perifollicular hyperpigmentation, is a distinguishing skin manifestation. This typical appearance, together with skin sclerosis, is a diagnostic sign of SSc. Terminal phalanges resorption, short and claw-like fingers (due to acro-osteolysis), and fingertip ulcerations are also usually seen.<sup>[<xref rid="R3" ref-type="bibr">3</xref>]</sup></p><p>A biphasic relevance between SSc and cancer has been demonstrated.<sup>[<xref rid="R1" ref-type="bibr">1</xref>,<xref rid="R2" ref-type="bibr">2</xref>]</sup> While cancer occurs within the first 5 years of SSc onset, the pathological immune reaction in cancer and some anticancer therapies may trigger autoimmunity, resulting in SSc and supporting the hypothesis that SSc may be a paraneoplastic phenomenon. Otherwise, prolonged inflammation, persistent immunosuppressive conditions secondary to either treatment or altered immunity and acquired genetic functional defect of mesenchyma in SSc may predispose to cancerogenesis.<sup>[<xref rid="R1" ref-type="bibr">1</xref>,<xref rid="R2" ref-type="bibr">2</xref>,<xref rid="R4" ref-type="bibr">4</xref>]</sup></p><p>A significant relevance between cancer and SSc implies that similar genetic settings and environmental risk factors are implicated in their pathogenesis.<sup>[<xref rid="R5" ref-type="bibr">5</xref>]</sup> In addition, they share some similar pathophysiological mechanisms, namely, immune dysregulation, vasculogenesis, fibrosis, oxidative stress, etc.<sup>[<xref rid="R2" ref-type="bibr">2</xref>]</sup></p><p>In 2011, Georgios Androutsopoulos and colleagues<sup>[<xref rid="R6" ref-type="bibr">6</xref>]</sup> reported a 43-year-old female with SSc, endometrial cancer (stage Ib) endometrioid type, and ovarian cancer (stage IIIc) endometrioid type. To our knowledge, our case may be the 2nd case of SSc with cancers of the female reproductive system. Though the diagnosis of SSc was made 1 and a half years later than endometrial adenocarcinoma, the skin lesions occurred more than 5 years earlier, which suggests similar pathophysiological processes, such as persistent chronic inflammation, immunologic derangement, may be implicated in both pathogenesis.</p><p>In summary&#x0ff0c;our case supports the existence of fundamental pathophysiological links between SSc and oncogenesis, with chronic inflammatory persistence and breakdown of immune homeostasis emerging as plausible unifying mechanisms.</p></sec><sec><title>Author contributions</title><p><bold>Conceptualization:</bold> Hui-Chang Yan.</p><p><bold>Data curation:</bold> Hui-Chang Yan, Cui Huang.</p><p><bold>Formal analysis:</bold> Hui-Chang Yan.</p><p><bold>Investigation:</bold> Cui Huang.</p><p><bold>Methodology:</bold> Hui-Chang Yan.</p><p><bold>Project administration:</bold> Hui-Chang Yan.</p><p><bold>Resources:</bold> Hui-Chang Yan.</p><p><bold>Writing &#x02013; original draft:</bold> Hui-Chang Yan, Cui Huang.</p><p><bold>Writing &#x02013; review &#x00026; editing:</bold> Hui-Chang Yan.</p></sec></body><back><fn-group><fn fn-type="abbr"><p>
<def-list><title>Abbreviation:</title><def-item><term>SSc</term><def><p>systemic sclerosis.</p></def></def-item></def-list>
</p></fn></fn-group><fn-group><fn fn-type="other"><p>All patients in this manuscript have given written informed consent for participation in the study and the use of their de-identified, anonymized, aggregated data and their case details (including photographs) for publication.</p></fn><fn fn-type="COI-statement"><p>The authors have no funding and conflicts of interest to disclose.</p></fn><fn fn-type="other"><p>The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.</p></fn><fn fn-type="other"><p>How to cite this article: Yan H-C, Huang C. Systemic sclerosis complicating endometrial adenocarcinoma: A case report. Medicine 2025;104:20(e42553).</p></fn></fn-group><ref-list><title>References</title><ref id="R1"><label>[1]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lepri</surname><given-names>G</given-names></name><name><surname>Catalano</surname><given-names>M</given-names></name><name><surname>Bellando-Randone</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Systemic sclerosis association with malignancy.</article-title>
<source>Clin Rev Allergy Immunol</source>. <year>2022</year>;<volume>63</volume>:<fpage>398</fpage>&#x02013;<lpage>416</lpage>.<pub-id pub-id-type="pmid">36121543</pub-id>
</mixed-citation></ref><ref id="R2"><label>[2]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tyndall</surname><given-names>AJ</given-names></name><name><surname>Bannert</surname><given-names>B</given-names></name><name><surname>Vonk</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database.</article-title>
<source>Ann Rheum Dis</source>. <year>2010</year>;<volume>69</volume>:<fpage>1809</fpage>&#x02013;<lpage>15</lpage>.<pub-id pub-id-type="pmid">20551155</pub-id>
</mixed-citation></ref><ref id="R3"><label>[3]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hasan</surname><given-names>S</given-names></name><name><surname>Aqil</surname><given-names>M</given-names></name><name><surname>Panigrahi</surname><given-names>R</given-names></name></person-group>. <article-title>HIV-associated systemic sclerosis: literature review and a rare case report.</article-title>
<source>Int J Environ Res Public Health</source>. <year>2022</year>;<volume>19</volume>:<fpage>10066</fpage>.<pub-id pub-id-type="pmid">36011703</pub-id>
</mixed-citation></ref><ref id="R4"><label>[4]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morrisroe</surname><given-names>K</given-names></name><name><surname>Hansen</surname><given-names>D</given-names></name><name><surname>Huq</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Incidence, risk factors, and outcomes of cancer in systemic sclerosis.</article-title>
<source>Arthritis Care Res (Hoboken)</source>. <year>2020</year>;<volume>72</volume>:<fpage>1625</fpage>&#x02013;<lpage>35</lpage>.<pub-id pub-id-type="pmid">31539207</pub-id>
</mixed-citation></ref><ref id="R5"><label>[5]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olesen</surname><given-names>AB</given-names></name><name><surname>Svaerke</surname><given-names>C</given-names></name><name><surname>Farkas</surname><given-names>DK</given-names></name><name><surname>S&#x000f8;rensen</surname><given-names>HT</given-names></name></person-group>. <article-title>Systemic sclerosis and the risk of cancer: a nationwide population-based cohort study.</article-title>
<source>Br J Dermatol</source>. <year>2010</year>;<volume>163</volume>:<fpage>800</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="pmid">20854403</pub-id>
</mixed-citation></ref><ref id="R6"><label>[6]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Androutsopoulos</surname><given-names>G</given-names></name><name><surname>Adonakis</surname><given-names>G</given-names></name><name><surname>Tsamandas</surname><given-names>A</given-names></name><name><surname>Andonopoulos</surname><given-names>A</given-names></name><name><surname>Decavalas</surname><given-names>G</given-names></name></person-group>. <article-title>Systemic sclerosis and multiple cancers of the female genital tract: prolonged survival following current treatment strategies.</article-title>
<source>Case Rep Rheumatol</source>. <year>2011</year>;<volume>2011</volume>:<fpage>392068</fpage>.<pub-id pub-id-type="pmid">22937444</pub-id>
</mixed-citation></ref></ref-list></back></article>